Novo Nordisk Partners with Emcure Pharmaceuticals in India
Novo Nordisk, the Danish company behind Wegovy, has partnered with Emcure Pharmaceuticals to increase access to its weight-loss treatment in India. Emcure will distribute and commercialize the 2.4 mg GLP-1 treatment under the brand name Poviztra. The partnership aims to strengthen distribution and marketing of semaglutide for weight loss, particularly through pharmacies and in regions … Read more